| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | B |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | C |
| 6. Replicate Analysis | B |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | B |
| 12. CI | C |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C5,7,8,10,12,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Plasma |
| Measurand | Insulin |
| Unit | pmol / L |
| Overall Analytical Principle Method | Immunoassay; RIA |
| Number of Subjects | 1177 |
| Number of Subjects included in BV estimation | 1177 |
| Ethinicity | Mixed |
| Age Mean / Median | 30.8 |
| Age Min | |
| Age Max | |
| Age SD | |
| Number of Males | |
| Number of Females | |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 72. |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | |
| Interval Units | Other |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 2 |
| Average Number of Samples Used for BV Estimation | 2.0 |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 25.2 |
| Calculated Confidence Intervals of CVi | Lower: 23.82, Upper: 26.60 |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: 53.43, Upper: |
| Analytical CV | 13.0 |
| Calculated Confidence Intervals of Analytical CV | Lower: 11.92, Upper: 14.29 |
| Measurand Mean | 66.36 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |